SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-106451
Filing Date
2021-08-16
Accepted
2021-08-16 17:06:22
Documents
5
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2124694-1_def14a.htm DEF 14A 511389
2 GRAPHIC lg_altimmune-4c.jpg GRAPHIC 21934
3 GRAPHIC sg_vipingarg-bw.jpg GRAPHIC 10842
4 GRAPHIC tm2124694d1-px_page1bw.jpg GRAPHIC 551247
5 GRAPHIC tm2124694d1-px_page2bw.jpg GRAPHIC 450004
  Complete submission text file 0001104659-21-106451.txt   1920726
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 211179602
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences